Daniel Witthaut1 and Stephan von Delft2
1 Evonik Industries AG, Corporate Innovation Strategy
2 University of Glasgow, Adam Smith Business School
I have missed more than a thousand shots in my career. I have lost almost three hundred games. Twenty‐six times I have been trusted to take the game‐winning shot and missed. I have failed over and over again in my life. And that is why I succeed.
Michael Jordan, former basketball player, entrepreneur, and chairman of the Charlotte Hornets
The development of a new business is an exciting entrepreneurial task. This chapter describes a model that has been proven in the chemical industry for how to recognize new business opportunities and how to develop them into growing, profitable businesses. The authors believe that it is not only the money spent on innovation that is critical for the success of one’s actions but a well‐structured process that gives guidance on the one side but leaves enough flexibility for creativity and entrepreneurship on the other. As we will show later, new business development in the chemical industry is a process that takes several years, often has a high rate of failure and typically requires a substantial amount of resources (e.g. cash, R&D personnel). Larger corporations therefore seize most new business opportunities in the chemical industry. In this chapter we will hence focus on how established chemical companies recognize and establish new businesses. In doing so, we do not intend to understate the role of innovative start‐ups in the chemical industry, but because most new products are developed by established players and as start‐ups often seek partnerships with these firms, from our point of view a focus on established firms is appropriate in the context of the chemical industry.
In this chapter you will learn about the context in which new business development occurs, about how and where to search for new business opportunities and how to implement them, and you will learn that failure is an intrinsic part of the new business development process. We will demonstrate that new business development matters but it does not happen automatically – new business development is an entrepreneurial endeavour that requires openness, creativity, analytical skills and a network with related industries.
New business development (NBD) is a process – the search, selection, implementation and capture of a new business opportunity – that can be organized and managed, and which occurs within the context of a firm’s innovation strategy and its organizational structure and culture. This context is a distinguishing factor between the creation of a new business by an independent entrepreneur and the creation of a new business inside an established organization. In this chapter, we will address how to manage new business opportunities in an established firm and how to align NBD activities with the context of the firm.
The NBD model depicted in Figure 6.1 is not only the basis for the structure of this chapter but has also proven to be a valuable guide for new business development activities in a leading specialty chemicals company. According to the model, a firm’s innovation strategy and its organizational structure and culture can be understood as the framework in which NBD happens. NBD projects in two distinct companies that rely on a similar NBD process may flourish or perish depending on the context in which the projects evolve. Thus, every organization needs both an appropriate context, shaped by the leaders of the organization, and an appropriate process for NBD, executed by its managers. Indeed, developing and implementing the firm’s innovation strategy as well as shaping an organizational culture in which innovation and entrepreneurial thinking can thrive are clearly a core leadership task. The first part of this chapter will therefore be about the role of innovation strategy and organizational factors, namely structure and culture, and how they affect the NBD process.
A firm’s innovation strategy is, like its operation or marketing strategy, closely linked to its business strategy,1 and it shapes and influences the NBD process. Since innovation should be aligned with the business strategy, it needs to be derived from and serve the business strategy. In fact, innovation strategy is vital to successfully implementing business strategy. Integrating the two is therefore important. A chemical company that runs a commodity business where products are sold in large quantities could, for example, have the strategic goal of creating high cash flows. As a consequence, the firm’s innovation strategy could focus on ensuring a competitive cost position and process development may be a dominant aspect in its innovation activities. In such a case the budget for NBD activities will be more restricted compared with an organization that focuses on growth. This may sound trivial to the experienced reader, however, it is crucial to clearly define the innovation strategy and make sure that it is communicated and understood throughout the whole organization. Without a clear innovation strategy, the chances of creating the right size of the NBD team, determining the necessary capital investments as well as selecting the right search area and scope of NBD projects are low.
Because the firm’s innovation strategy should be linked and aligned with the choices and consequences made at the top of the firm, a close look at the organization’s mission and vision and its strategic goals and objectives is a good starting point for developing the innovation strategy. The mission of the Dow Chemical Company, for instance, is “to passionately create innovation for our stakeholders at the intersection of chemistry, biology and physics” and its vision is “to be the most valuable and respected science company in the world” [2]. Dow’s mission statement highlights the importance of innovation and it sets a broad framework for innovation and NBD: its innovation and NBD activities should be focused at the intersection of chemistry, biology and physics. Similarly, Dow’s vision statement indicates that the company has a strong focus on R&D (“Science Company”), which shows that R&D expertise is a core factor for its innovation process. Taking a closer look at Dow’s strategic priorities allows further determination of what related innovation goals the company should pursue. As an example, the company aims to “launch new products in Dow Packaging & Specialty Plastics, Dow AgroSciences, Dow Electronic Materials and Dow Coating Materials, and deliver new margins in these businesses in 2014/2015” [3], which further clarifies the innovation framework, as priority areas are more clearly defined compared with the company’s mission statement. The analysis of the organization’s strategic priorities may thus start with broad statements like “become the market leader through rapid product introduction,” complemented by an analysis of objectives such as “achieving 25% of total sales from sales of products and applications introduced in the last 5 years by 2020”. Derived from such business goals and objectives, specific innovation goals and objectives can be developed. The goal of this exercise is to ensure that the innovation strategy answers the question: How do NBD activities fit into the organization’s overall plan? In turn, another essential aspect of the innovation strategy is to prioritize possible new business opportunities that organizations can pursue. The better an NBD project fits into the business strategy of the organization, the more likely it is to get approval for investment in the project – something that is particularly important in chemical and pharmaceutical companies where large capital expenditures are typically required to implement new business ideas. As an example, BASF has identified a number of growth areas, such as batteries for mobility, e‐power management, organic electronics and functional crop care, from broader global needs (resources; environment and climate; food and nutrition; quality of life) on a corporate level. The projects that BASF’s new business subsidiary, BASF New Business, has developed, for example, high‐temperature superconductivity (e‐power management) and OLEDs for displays and lighting (organic electronics), fit into these growth fields. Similarly, Evonik Industries has identified a number of global megatrends, such as resource efficiency and health and nutrition. Evonik has organized its operating structure around these megatrends in the form of independent companies, such as Evonik Nutrition & Care GmbH or Evonik Resource Efficiency GmbH. Accordingly, the company invests in NBD projects that, for instance, help to utilize resources more efficiently, and its corporate venture capital activities (bundled together in a unit called Evonik Venture Capital) focuses on investments in young companies that align with Evonik’s growth areas.
Without such clear growth areas, the search for specific new business opportunities is unfocused, projects would most likely remain unrelated and the firm’s innovation and NBD efforts would not be effective. Companies may also further specify growth opportunities of global megatrends. As depicted in Table 6.1, the chemical company Wacker distinguishes between broader economic opportunities and more precise strategic and performance‐related opportunities. Statements such as “higher plant productivity” indicate that process innovation is an important aspect of Wacker’s innovation efforts, and statements along the lines of “region‐specific product development” point at how the company structures its global innovation activities.
Table 6.1 Growth opportunities at WACKER.
Data source: [4]
Overview of Wacker’s business opportunities | |
Overall economic opportunities | Growth in Asia and other emerging countries |
Sector‐specific opportunities | Good product portfolio for megatrends, such as energy, greater prosperity, urbanization and digitization |
Strategic opportunities |
|
Performance‐related opportunities |
|
In summary, the innovation strategy indicates how NBD (or innovation in general) helps the organization to achieve its goals and objectives. This also serves as an important guiding principle and motivation for everyone involved in NBD activities: knowing where and why to build new businesses is a fundamental principle for the success of an NBD project. Moreover, the role of innovation and NBD in achieving the overall business goal should not only be recognized by NBD team members or R&D staff but also by other members of the organization so that everyone has a common understanding. Therefore, communicating the innovation strategy is a top priority within every organization.
Because innovation goals and objectives cannot stand in isolation, an analysis of the current competitive position of the organization in terms of innovation and NBD activities is another step in developing the innovation strategy [5]. To this end, the general strategic planning tools that you have learned about in the earlier chapters of this book, for example, Porter’s Five Forces framework and SWOT analysis, can also be applied for formulating the innovation strategy. By analysing the current competitive situation, companies can identify what their current offering lacks compared with competitors’ offerings or future customer requirements and thus determine whether incremental or more radical changes to the product/business portfolio are necessary. Overall, a successful innovation strategy takes into account a full range of stakeholders, including suppliers, competitors, distributors, employees and, particularly, existing and potential customers. Thus, everyone who has an interest in the outcome of the innovation strategy (or in other words who will judge the success or failure) should be considered. For example, a chemical company won’t embrace a new additive for aqueous coating systems that significantly improves substrate wetting, but which would demand a new coating technology, unless customers are willing to adapt their coating technology as well. Similarly, people like senior management who affect innovation and NBD activities, contribute resources (time, people, cash, etc.), and eventually gain benefits from a successful innovation strategy and its outcomes should be taken into account.
Finally, developing the innovation strategy should be repeated on a regular basis since the strategic goals of a company and the competitive environment of the firm change over time – in other words, innovation strategy needs to be adaptive to change. Internal and external circumstances (over which a company’s management has no control) demand interim decisions that affect the innovation strategy of the company. Moreover, because no chemical or pharmaceutical company can possibly foresee the timing or even the nature of technological change, innovation strategy needs room for adaptation. For example, in 2000, the life science company DSM introduced a strategic initiative called “Vision 2005”, which focused on transforming DSM’s portfolio from bulk chemicals to specialties, while its “DSM in Motion” initiative, introduced in 2010, focused on maximizing sustainable, profitable growth. Both goals certainly have important but different consequences for DSM’s innovation strategy and in turn for its portfolio of NBD projects.
NBD teams in the chemical industry typically bring together people with different characteristics, for example, age, functional background and personality, who work together to identify and develop new business opportunities. In fact, numerous innovation studies have shown that team heterogeneity is an important driver of innovation [6–9]. Some companies such as the Swiss health‐care company Roche have begun to recognize differences in team characteristics and structure their NBD activities in accordance with the team members’ personalities, that is, such companies create fit between the content of an NBD activity (e.g. searching) and certain personalities. In doing so, these companies recognize that some people are exceptionally good in searching and selecting new business ideas, for example due to their job experience or their ambition to try something new, while others are exceptionally good at implementing these ideas, for example because they are good negotiators and know how to communicate with stakeholders. As an example of such a practice, BASF has organized activities in its new business unit into two sub‐units: “Scouting & Incubation” and “Business Build Up”. In recognizing such differences and separating the activities of search and implementation into different organizational sub‐units, companies can support the NBD process. The task of the NBD team leader would then be to ensure that team members of different sub‐units interact.
When combining different sub‐units into one NBD unit, most chemical companies structurally separate their NBD units from the operating business. The previously mentioned BASF New Business unit is, for instance, organized as a subsidiary of BASF, that is, it is an NBD unit on a corporate level. In addition to such corporate NBD units, companies may also have NBD units at a business unit level. Whether a business unit has its own NBD unit depends on the characteristics of the respective business unit. Business units that are characterized by high growth prospects and a high market share are more likely to have an NBD unit than business units which have a high market but low growth prospects. In the case of a diversified company, exploiting (and possibly creating) synergies between the NBD units of different business units would be an objective for the NBD unit at the corporate level.
The reason for separating NBD activities from the every‐day operation of a company is differences in short‐ versus long‐term orientation, management principles and culture. For instance, operating units typically face a strong pressure to fulfil short‐term performance goals, have to make sure that they generate today’s income and may have to focus on saving costs. NBD units in contrast have a long‐term orientation, have to make sure that they generate the future income of the firm and NBD projects are initially not profitable. However, even though such a structural separation is advisable, the NBD unit cannot stand in isolation. Frequent collaboration and interaction with other units such as marketing, sales and production, as well as communication with the general management are important – NBD is in its very essence a coordination function. NBD teams naturally have to connect to internal and external parties: internally to functions such as R&D, marketing, sales, controlling, the firm’s legal department and corporate functions, such as corporate strategy; and externally, to parties such as other companies, universities, research institutions, suppliers and industry associations.
As explained, running an existing business and developing a new business are very different from each other. Whereas in an existing business, customers, competitors and products are well known, new businesses often start from scratch, move into uncharted territory and naturally face a high level of uncertainty. Because of these unknowns, new business development is characterized by a higher degree of failure. A recent study among 108 business units in the chemical industry with more than US$2 billion in sales, by the consulting company McKinsey, shows that the average success rate for a typical NBD project is only 15% [10]. In other words, 85% of NBD projects fail (see Table 6.2). Moreover, the time to commercialization is substantially higher for NBD projects compared with extensions of existing businesses (e.g. a product‐line extension into an existing market), and may take 10 or (particularly in pharmaceuticals) even 20 years.
Table 6.2 Success rates and time to commercialization for different innovation projects (McKinsey study). Adapted from [10].
Product‐line extensions into existing markets | Product‐line extensions into new markets | New‐product launches in existing markets | New‐product launches in new markets |
|
Familiarity with market | High | Low | High | Low |
Familiarity with technology | High | High | Low | Low |
Time to commercialization | 2–5 years (average 4) |
2–7 years (average 5) |
6–15 years (average 11) | 8–19 years (average 14) |
Success rate | 40–50% | 30–40% | 30–40% | 15–20% |
Margin | 0–5% | 0–10% | 0–10% | 0–60% |
Given the high failure rates, NBD team members need to be able to accept failures and have a high tolerance to frustration. Furthermore, it is not only the NBD team that needs to be aware of high failure rates but also the senior management of a company, responsible for both existing and future business of the company (regardless of whether they have experience in building new businesses or not). Of course, high failure rates should not be a general excuse for failed NBD projects but as long as failure results in learning (“never make the same mistake twice”), management needs to accept a higher failure rate in NBD while also ensuring successful projects. Overall, the associated uncertainty and low success rates of NBD projects demand an organizational culture that is not only characterized by low risk aversion and tolerance to failures but accepts failures as a normal aspect of seizing a new business opportunity.
Organizational culture refers to a “complex set of values, beliefs, assumptions and symbols that define the way in which a firm conducts its business” [11: 657] and describes the extent to which values are shared by members of the organization [12]. The culture of a company has important implications for NBD activities. Evonik Industries, for instance, states that the “culture of a company determines whether—and how fast—employees are able to drive forward good ideas and convert them into a profitable business” [13]. Hence, an organizational culture that is characterized by high control, high stability and a high need for predictability, will likely impede individual creativity, hamper motivation of R&D and NBD team members and ultimately prevent the identification of new business opportunities, because employees will keep ideas to themselves to avoid risks. Many chemical and pharmaceutical companies recognize that such an organizational culture will corrupt attempts to develop new businesses and new products. Many companies therefore promote an organizational culture that welcomes creativity and innovation in all its facets. One example of this is Evonik’s recent innovation initiative. According to Evonik’s Chief Innovation Officer (CIO), “we’re addressing ever shorter innovation cycles, more complex problems, and more demanding conditions. This is why we launched our Leading Innovation initiative last fall. With our global Leading Innovation initiative we are promoting a culture of innovation, with courage to break new ground, in which our employees are encouraged to take risks and which is based on trust, close cooperation and openness and which also rewards courage to innovate. Everyone at Evonik has to embrace innovation” [14].
In summary, the first part of this chapter demonstrates that structure should be managed simultaneously with innovation strategy and organizational culture to facilitate new business development. In the next part of the chapter, we will now take a look at the NBD process as depicted in Figure 6.2.
The search for new business opportunities is more than just an application of different idea generating tools. It rather starts with connecting to the innovation strategy of the company and answering three basic questions: (1) Why should we search for new business ideas? (2) What kinds of business ideas are requested and hence searched for? (3) Where should we search for new business ideas? Only if these questions are answered, can the actual ideation process, that is, the question of how to get new ideas, be addressed. Process‐wise, the definition of innovation search fields takes place at the intersection of the innovation strategy (which is usually discussed once a year) and the idea management process (see Figure 6.2). At Evonik, the idea management process is called the idea‐to‐profit (I2P®) process and includes the generation of new ideas up to the successful market launch.
This is the first link to the innovation strategy. Everyone involved in NBD should be crystal clear on what the overall goal of the NBD activities is. General statements such as “making money” or “building a sustainable, profitable business” are not precise enough for creating the necessary understanding about the goal(s) to be reached. A precise answer to the question of why one is searching for a new business idea depends of course on the company itself. Consider a company that has ambitious growth targets. Depending on the time horizon of these targets, the company might consider growth through a number of acquisitions, a combination of acquisitions and NBD, or primarily through NBD.2
This is the second link to the innovation strategy. The answer to this question depends on the general expectations a new business needs to fulfil. These conditions build the framework for searching for new ideas and include, but are not limited to, expectations regarding collaboration with external partners, demands about time‐to‐market or time‐to‐breakeven, budget restrictions, or requirements with respect to the profitability of the business, for example, certain EBITDA margins that need to be achieved.
This question can also be derived from the innovation strategy with respect to the market segment or field of application where a new business should be built. As depicted in Figure 6.2, the search process starts with an analysis of market trends (external analysis) and analysis of existing competencies (internal analysis). There are two general ways to assess the internal competencies in relation to market trends: traditionally, one would compare the existing competencies (or means the company has) to those required to seize a given market opportunity. If competencies are missing, the company would have to acquire or build new competencies. This approach can be classified as an outside‐in approach because the starting point is the external analysis – the environment determines if the existing competencies are sufficient. Another way to start the trend analysis is to define the unique competencies that already exist and search for potential fields that can be seized by means of these competencies. While both approaches might look very similar, they are very different in their nature for identifying potential NBD search fields. Consider the simple picture of cooking a meal: the outside‐in approach is to have the recipe (the market trends derived from an external analysis) and then acquire the necessary ingredients (the competencies) to cook the desired meal. In contrast, the inside‐out approach starts with the existing ingredients (the competencies) that can be combined to create various types of new meals; an approach that one can term “creative cooking”. The reality will be between the outside‐in and inside‐out approaches because it is not only the environment of a firm that determines its path (with the firm having no influence at all) nor is it the firm that can always shape or influence its environment. Hence, defining new search fields is a combination of market trends and competencies with an emphasis on the fact that such a combination can be realized with existing and non‐existing market access and with existing or non‐existing competencies. But, a company should have either access to a market or possess a competence – one of the two should be present. In other words, without any means in‐house and without any access to a market, internal development through NBD is questionable and an acquisition might be more promising.
To illustrate the application of the Why‐, What‐ and Where‐question, consider an example from Evonik Industries, former3 business unit Advanced Intermediates (e.g. active oxygens, specialty catalysts and polymer additives). In order to enable additional growth, the unit considered the idea of growing its product portfolio of “advanced intermediates” by focusing on methods to replace petroleum‐based chemicals. The industrial branch devoted to the use of living cells and enzymes to synthesize products that can replace petroleum‐based chemicals is known as white biotechnology. Because white biotechnology has prospered in recent years and because Evonik has strong competencies in this area, especially in its animal nutrition business, the idea was to search for new business opportunities in the area of bio‐based advanced intermediates. However, as all of these opportunities would have required investments in the three digit million Euro range, the idea did not fit with the overall business strategy of Evonik and was, therefore, not developed further. As an alternative, Evonik considered building on its existing technology and product know‐how in the field of amine chemistry and applying its competencies in a different application field. The idea was to offer customers a chemical absorbent in the area of acid gas removal that would not require process modifications. This idea, later commercialized as CAPLUS®, required much lower investments and, thus, had a better fit with the firm’s innovation strategy. Hence, while the “What”‐question did not fit with Evonik’s strategy in the case of bio‐based chemicals, its newly developed specialty amine formulation CAPLUS did fit. In order to be successful with an initial idea, it has to demonstrate fit in all three dimensions of the Why‐, Where‐ and What‐ questions. If an idea does not fit for any (significant) reason, like the mismatch of the required and available investment for bio‐based chemicals, the idea should not be further developed and the resources allocated to other ideas that better fit with a company’s strategy.
In addition to collaborating with internal partners,4 new business development involves connecting the firm to external partners such as suppliers, industry associations and universities. Hence, new business development entails the creation of a network beyond the boundaries of the firm. To build such a network, the new business development manager needs to talk to (existing and potential) customers, attend industry conferences and science fairs, consult with experts inside the chemical industry but also with those outside the chemical industry, for example, in the automotive or construction industries. It also entails reading scientific articles, industry magazines and management literature and studying patent landscapes.
Networking with a diverse group of external partners enhances business intelligence (e.g. by obtaining customer know‐how), provides access to a wide range of ideas and complementary competencies and increases flexibility in the business development process. In fact, inter‐firm networks and strategic alliances are increasingly a source of competitive advantage [16–21]. This includes concepts such as “Open Innovation” – a term promoted by Henry Chesbrough from the Haas School of Business – that assume that “firms can and should use external ideas as well as internal ideas and internal and external paths to market” [22: 1]. Open Innovation is a holistic approach to innovation management that not only means opening a firm’s innovation process to external parties (with ideas flowing inside and outside the firm) but goes beyond simply using external sources of ideas and technologies [23]. Open Innovation can be used to change the way companies manage intellectual property and guide the integration of exploration‐oriented firm‐level capabilities and resources (e.g. internal R&D capabilities) with exploitation‐oriented capabilities and resources (e.g. supply chain management). The concept, therefore, has a significant strategic element as it concerns the strategic capabilities of the firm, such as a firm’s ability to manage alliances.
To better utilize external sources of innovation, chemical and pharmaceutical companies increasingly employ a variety of techniques to connect to external parties. The chemical company Evonik, for example, regularly holds so‐called “Evonik Meets Science” events in Germany, China, Japan and the United States to strengthen its networks with leading international researchers. In these events managers from Evonik exchange knowledge with scientists from different disciplines and institutions [24]. The consumer goods company Henkel organizes a competitive fair, called the “Henkel Innovation Challenge”, where students from all over the world come together in teams of two and imagine being a new business development manager. The students “develop their own vision of life in 2050 and develop a new Henkel product or technology for the future. With their concepts, which also take into account Henkel’s sustainability strategy, they compete with international students around the world: Who has the best idea and who will succeed in the national and international final?” [25]. The pharmaceutical company GlaxoSmith Kline (GSK) operates a website where it publishes so‐called “Wants”, that is, technologies or innovations the company is looking for. If external parties (e.g. individual researchers or a team of researchers) have an innovative idea that matches GSK’s wants, they can submit the idea and potentially partner with GSK. According to the company, “[t]he ultimate goal for GSK […] is to in‐licence and commercialize innovative technologies matching our strategic wants. Through appropriate legal agreements, we hope to link external innovative technology to our global brands—a process that can result in a win for GSK and a win for innovators” [26]. On average, the early stage review for new ideas submitted to GSK takes 3 months, and12–18 months to plan a development programme and execute legal agreements in the field of consumer healthcare. Box 6.1 discusses another approach to finding external ideas – ideation jams.
After collecting several new business ideas, the most promising ideas need to be selected (because of resource constraints a chemical company cannot pursue every idea). The challenge, of course, is to determine which business opportunities or projects are worth pursuing and which are not. In this section we will present four approaches to selecting new business opportunities that have proven to be successful in business practice. While you have already learned about certain criteria to select new product ideas in Chapter 5 (see e.g. Cooper’s Stage‐Gate® model5), we will now focus on managing the selection of new business opportunities in areas where uncertainty is higher and where the firm has limited experience in terms of a technology and/or market. In contrast to methods such as discounted cash flow analysis, which are biased against late returns and uncertainty of NBD projects, the methods presented here are particularly suitable in the context of new business development. The selection process is primarily focused on the first part of the I2P process (see Figure 6.2), where the number of ideas from the fuzzy front end is reduced to a manageable number of projects.
While the growth needs of large chemical companies demand investments into radical product innovation and new business development, studies show that the majority of projects in firms’ development portfolios focus on continuous improvements of existing product lines and established businesses [27]. Hence, despite the need to invest in a few but risky NBD projects, firms often rather tend to approve a large number of safe projects that result in incremental innovations or opportunities that improve businesses that already exist.
Although the tendency of established firms to bet on projects with certain outcomes is not surprising, focusing on incremental developments during the selection process has two key disadvantages. Firstly, though necessary for continuous improvement, safe projects don’t contribute much to the growth needs of the firm and its profitability targets. Secondly, selecting a large number of safe projects congests the firm’s project pipeline, resulting in “traffic jams” that delay NBD projects. As a result, firms fail to achieve their revenue goals and may even risk future competitive advantage. Accordingly, what companies need is a systematic and disciplined selection method, resulting in a balanced portfolio of safe projects that sustain the present businesses of the firm (e.g. through incremental product innovations) and more risky projects that build future competitive advantage and contribute significantly to the growth of the corporation.
Such a tool is the so called R‐W‐W (“real, win, worth it”) screen – a method developed by George Day from the Wharton School – which lays out a series of questions about every NBD project, its potential market and a firm’s capabilities – “not for making go/no‐go decisions but, rather, […] to expose faulty assumptions, gaps in knowledge, and potential sources of risk” [27: 114]. The R‐W‐W method is used by companies such as Evonik, Honeywell, Novartis and 3M to assess the potential of business ideas and select individual new business development projects [27]. In the following we will summarize Day’s method, apply it to the context of the chemical industry and highlight key aspects.
Based on the R‐W‐W method, the potential of an NBD project is evaluated in three categories: product‐market relation (Is it real?), competition (Can we win?) and value (Is it worth pursuing?). Following these three first‐column questions (see Figure 6.3), the screen guides the NBD team to ask six fundamental questions (second column of Figure 6.3): Is the market real? Is the product/service real? Can the product/service be competitive? Can our firm be competitive in this business? Will the product/service be profitable at an acceptable risk? Does launching the NBD project make strategic sense?
Usually, not all of the second‐column questions (see Figure 6.3) can be answered at an early stage of developing a business opportunity but these questions are a helpful guide to navigating through the unknown jungle of unproven business concepts and should be repeatedly asked throughout the different stages of the NBD process. Specifically, the R‐W‐W screen points at the type of questions to be asked and where an NBD team should focus its resources in order to determine the viability of a business idea. As an example, when the initial answer to the question “Is the market real?” is “maybe”, the NBD team has to explore ways to turn the answer into a yes. If, after a thorough investigation, the definite answer to any second‐column question is no (i.e. the team cannot identify any way to change it into a yes), then the project will typically6 be terminated. In such a case, one should document the reasons why it has been stopped (in order to come back to the project when market conditions have changed or, in case a project has been terminated but later successfully exploited by a competitor in order to explore why the project was dismissed).
In supporting the NBD team answering the six core questions, the team can deal with a number of sub‐questions (third column in Figure 6.3)7:
At Evonik Industries, the R‐W‐W screen is applied especially in the first three stages of the idea‐to‐profit (I2P) process (see Figure 6.2). Therefore, project leaders would need to answer a few questions in Stage 1, revisit these questions in Stage 2 and add some more questions and repeat the process in Stage 3, to be able to answer all of the previous questions that are often based on reasonable assumptions.
In order to create and deliver a product or a service, a specific set of activities needs to be performed. This set of activities is, in line with the process‐view of organizations, known as the value chain [28]. The value chain describes what activities a firm needs to undertake to create value.8 But, the value chain is not only about choosing activities, it is also about how to link (e.g. sequence) activities. When engaging in NBD, it is important to understand this chain of activities and their linkages because it allows evaluation of the feasibility of an NBD opportunity and, thus, selection of promising projects.
Compared with building a new business in a business‐to‐consumer (B2C) context, such as online retailing, chemical companies (primarily) build businesses in a business‐to‐business (B2B) context that is characterized by smaller numbers of potential customers (e.g. 1–50) and by smaller numbers of suppliers from which one can source raw materials (e.g. 1–30). The starting point in constructing the value chain is the customers and their needs (i.e. what does the customer actually want?). Discussions with potential customers at very early stages of NBD allow creation of insights on product requirements, potential quantities and product prices that, in turn, enable firms to analyse the consequences on the value chain and might also lead to joint development agreements with customers. Thus, based on an analysis of customers’ needs, one can start to think about the components required to meet those needs (e.g. production facilities with a certain capacity) and the design of the processes for creating, communicating and delivering the offering (e.g. given the requirements, do we have the marketing and sales capacity to serve our customers in a reproducible fashion?).
Furthermore, the value chain should not only be analysed in the direction of the outputs, which is forward towards the customer, but also in the direction of the inputs, which is backward towards the suppliers. In NBD, one needs to understand where one can source the required raw materials, at what price and in what quantities. Supplier integration during the early stages of NBD may not only allow a better understanding of inbound‐logistics in one’s value chain but also reduce development time and improve quality of new products [29, 30]. Integrating both customers and suppliers is, hence, an important and advisable aspect of NBD to understand and fine‐tune a business model to the needs and restrictions of the market one aims to enter (for more insights into customer and supplier integration see Chapter 8).
To illustrate the role of understanding and mapping the value chain for NBD, consider the following examples from Evonik Industries:
Both examples illustrate that it is not sufficient to understand the technology or the product alone, but companies also need to understand the whole value chain, especially with respect to the sourcing of raw materials and the markets their customers are selling to. Hence, NBD projects should be assessed in terms of how well the value chain is understood towards the supply side, that is, suppliers, and how well the value chain is understood towards the demand side, that is, the customers.
Another way to approach the selection of NBD projects is discovery‐driven planning. This method – developed by Rita McGrath from the Columbia Business School and Ian MacMillan from the Wharton School – focuses on testing and re‐evaluating assumptions and is, hence, particularly suitable for the unpredictable setting of NBD projects [31]. In the following we summarize McGrath and MacMillan’s method, apply it to the context of the chemical industry and highlight key aspects.
Discovery‐driven planning is a tool that takes the fundamental differences between planning for an established business and planning for an NBD project into account [32]. Conventional planning tools such as discounted cash flow or net present value analysis are based on the premise that future returns can be extrapolated from past experience. These methods are therefore appropriate in the context of established businesses, where technology is well understood, forecasts are reliable and market conditions are relatively safe. By contrast, the context of an NBD project, particularly during the early stages of development, is by its very nature uncertain, difficult to predict and not obvious. Instead of relying on existing knowledge that doesn’t change during the development of a project, NBD projects rely on assumptions that often turn out to be wrong. Conventional planning tools that require reliable data are hence in general not suitable to select NBD projects. What is needed is a tool that allows discovering the potential of a project as new data are uncovered. Discovery‐driven planning is such a tool that “systematically converts assumptions into knowledge” [31: 44]. As depicted in Figure 6.4, discovery‐driven planning is based on a five‐step process to develop and select NBD projects.
The first step is to create a reverse income statement. Instead of estimating the revenues and then calculating the profits for each project, a reverse income statement starts with the required profits. Following this approach, the NBD team will begin with the required profits and then work backwards to the revenue necessary to deliver the required profits and the allowable costs (required profits = necessary revenue – allowable costs). Accordingly, the team has to define what the profit margin and the absolute profit should be at a minimum. To calculate the required profits, we must understand that the project should: (i) significantly contribute to the total profits of the firm and (ii) compensate for the investment risk (alternatively, the chemical company could invest in an established business). If, for example, the existing business has an EBITDA9 margin of 20% then the new business should have a margin of about 25% (i.e. in this example an NBD project must deliver a premium of 5% to compensate for investment risks). Here, the absolute profit should be in balance with the amount of resources and the expected risk. If the upfront costs are, for instance, several million Euros over several years, the targeted absolute profit, such as EBITDA, should be a two digit Euro million figure. Based on these two figures one can then calculate the necessary revenues and derive from this the necessary volumes and prices. Already at this stage one can double check if the necessary volumes lead to a reasonable and achievable market share. Going further one can now also calculate the allowable cost for production, general and administrative expenses, and marketing and sales expenses. For example, in the case of the previously mentioned CAPLUS project (see also Box 6.2), analysing how fast Evonik can ramp‐up production volumes if customers are willing to replace their existing amine scrubbing agent, enables the NBD team to estimate what resources (e.g. sales forces) are necessary to fulfil the demand. Such an analysis not only creates a more detailed but also a more realistic picture of the business opportunity compared with deriving volumes from aspired market shares.
In a second step, the value chain is laid out, describing key activities necessary to run the NBD project. Activities that create value are, for example, inbound logistics (e.g. receiving raw materials), production, marketing and sales and services (e.g. training). The operations specifications also allow identifying activities that are most significant in terms of operating costs and test how the existing value chain of the business unit is affected by the NBD project. Looking at related chemical businesses allows identifying typical operation standards such as plant utilization, asset to sales ratios, or other key performance indicators that can be used to determine whether a project holds together and to test and adjust underlying assumptions. The goal of this exercise is not to create the most accurate but a reasonable model of the logistical and economic reality of the new business.
The third step of discovery‐driven planning is to create an assumption checklist in order to track assumptions. This is an important step, as the model will be based on a number of assumptions due to the natural uncertainty that comes with an NBD project. Keeping this checklist is an important discipline to ensure that each assumption is flagged and tested as NBD projects unfold. This is a key advantage of the discovery‐driven planning, not only because it allows tracking of the assumptions but also because the tool facilitates the discussion with senior management. It lays out clearly not only the promised additional sales and profits (which every manager will happily accept) but also the necessary resources with respect to cash and employees that need to be committed in order to capture the benefits. Furthermore when, for example, assumed sales need to be adjusted, discussing the reason for this adjustment allows making changes in assumptions transparent and, therefore, sets the basis for constructive discussions.
Next, the company uses the new data to loop back the entire process into a revised income statement. At this step, the NBD team needs to ensure that all the assumptions are in line with the figures in the income (or profit and loss (P&L)) statement. Having transparent assumptions and figures, one can see if the entire business proposition hangs together or not. If, after several tests, the performance requirements cannot be met, the NBD project should be terminated and another project selected.
The fifth and final step in discovery‐driven planning is to use milestone events to test assumptions. This allows NBD managers to formally plan while ensuring learning.10 In contrast to conventional planning tools, the idea of milestone planning is not to focus an NBD manager on meeting a plan but rather to monitor the progress of the new business opportunity. Essentials are to further update the assumption list (if necessary) and to postpone major resource commitments until evidence from a previous milestone indicates that assumptions are still valid. If an NBD project does not pass a milestone test and the company does not see any way to redirect the project, the project would normally be terminated.
Another view on the selection process is not looking at a single idea but rather at the overall portfolio of ideas and projects. Portfolio concepts such as the BCG‐matrix (Boston Consulting Group) in the case of corporate strategy are frequently used in management practice and can also be applied to the selection of new business opportunities. In the context of NBD, the following concepts have been used by a leading specialty chemical company:
Having identified and selected a promising business concept one could assume that from this point the progress is linear and foreseeable. One could imagine that managing an NBD project is straightforward after core questions about product–market relations, competition and value are addressed, and milestone planning is used to test initial assumptions. But this is simply not the case. The uncertainty around the project is still very high and one should expect many loops, delays and detours until the new business becomes real and a scalable business model unfolds.
Implementing a new business demands experimenting rather than elaborative planning, using customer feedback early rather than relying on intuition (or even a dream) for too long, and it requires spending less time and energy on preparing the perfect product/service and more on piloting a new way of doing business. A methodology that takes these differences into account is the “lean start‐up” concept from Eric Ries.12 The lean start‐up method recognizes that managing new businesses is different from managing established businesses. Despite its name, it is not only start‐ups that can benefit from this method. In fact, scholars like Steve Blank emphasize that “some of its biggest payoffs may be gained by the large companies that embrace it” [35: 66]. In the following we will summarize Ries’s method, apply it to the context of the chemical industry and highlight key aspects.
To illustrate the idea behind the lean start‐up method, consider a chemical company that has selected an NBD project on asymmetric catalysis for implementation. The company knows that the demand for enantiopure compounds – particularly in the life sciences – is growing and has established a reverse income statement for this project following discovery‐driven planning.13 Also, together with colleagues in the firm’s R&D department, the NBD team has confirmed that the proposed synthesis is in principle highly selective and should be robust for a number of natural products, the team knows that the size of the market is adequate and it has also established an agreement with a small biotechnology firm that holds an important patent and has certain process know‐how believed to be relevant for the final production of the new chiral catalyst used in the reaction. Together with its partner, the firm is now ready to proceed with the project. Traditionally, the company would now ask to sequence project activities, such as further developing and testing the synthesis in the firm’s R&D labs, creating 5‐ to 10‐year forecasts for profits and cash flows, to identify potential bottlenecks and the critical path of the project, to monitor and control adherence to the project plan and, finally, to launch the product after all technical difficulties have been solved. Thus, the company uses a project or business plan to execute the NBD project. The downside of this approach is that only after launching the new catalyst, that is, when the company’s sales forces are asked to sell it, does the chemical company get feedback from customers. Hence at that point, our chemical company learns the hard way that customers have no need for a new catalyst, cannot or are not willing to adapt their production processes despite the technical superiority of the new catalyst, or that it had targeted the wrong customer segment.
Of course, our example is simplified, but in the context of NBD such a situation occurs more often than one might expect. Far too often companies work month after month or even for years on implementing an NBD project in accordance with the project plan, before the brutal reality of the market destroys all their aspirations (or we might even call it “dreams”). This happens for two reasons. First, because companies wait too long before they involve the customer in NBD. Instead of spending months behind an office desk, writing the perfect project plan and then executing this plan for years, companies need to ensure that they get early feedback from customers. The problem in NBD is that it is sometimes not that easy to understand what the customer actually wants (e.g. needs cannot be clearly expressed or the customer does not know what to demand in five years’ time) or, more importantly in the uncertain context of NBD, it is often simply not clear if the initially targeted customer is going to be the final customer. Who should be asked for feedback if the chemical company does not know who the customer is in the first place? The second reason is that companies often focus too much on executing the project plan after they have selected a promising NBD project. This problem occurs because established companies are usually very efficient in executing a project plan and therefore have a tendency to utilize this strength. However, in the context of NBD it is important to understand that focus should be on effectiveness rather than efficiency or, put simply, you need to make sure that you implement the right it before implementing it right. Executing a detailed project plan that includes a 5‐ to 10‐year forecast for profits and cash flows, a definition of the problem to be solved and a description of the offering that solves the problem, is often no more than a static document reflecting the assumptions of its creators. Because no one in the chemical or pharmaceutical industry can possibly foresee the technological or economic context of a new business that ventures into the unknown, it is crucial to first discover what the right business is before efficiently executing it. A method that takes both these problems into consideration is the lean start‐up method.
Lean14 start‐up is a scientific approach to developing and implementing new businesses that focuses on testing two key hypotheses: the value hypothesis and the growth hypothesis. Using the term hypothesis reminds us that every NBD project is based on a series of assumptions and we need to conduct experiments to find out if the project is on the path to becoming a sustainable business [36]. The value hypothesis is about discovering whether customers find the offering valuable or not. Thus, the NBD team needs evidence – not a plausible premise or a good story – that customers are willing to buy the new product. The growth hypothesis is about questioning how to scale the business, given that the value hypothesis has been confirmed. Thus, to implement an NBD project: (1) evidence must exist that customers find the business concept convincing and valuable and (2) the business must be repeatable and scalable. Testing the value and growth hypothesis early allows starting validated learning before too many assumptions about the project have accumulated.
To test the value and the growth hypothesis, the lean start‐up approach suggests engaging in customer development and, closely linked to customer development, agile development. Customer development focuses on going out of the company and asking potential customers and partners for feedback about the company’s initial assumption of how it creates and captures value with the new businesses, including product characteristics such as functionality and price, the revenue model, brand identity and potential strategic alliances and supplier relationships. The focus is on rapid adjustment of the initial hypothesis: NBD teams that follow the lean start‐up method create a minimum viable product and get customer feedback to revise assumptions. Sometimes the minimum viable product is a product that has the same or very similar characteristic as the existing product that is currently in use (“Would you buy a catalyst with the following features at the following price?”) or an offer to buy a product on a website. A chemical company producing hydrophobing agents could, for example, offer a new agent on its website to see if customers are willing to klick on the purchase button. If so, the company has learned that there is a general interest in the product. There is no doubt that setting up a website is not sufficient to get detailed customer feedback, but if not a single customer klicks on the purchase button, then a cheap experiment can reveal the same information as the chemical company from our previous example obtained after trying to launch its NBD project and spending hundreds of thousands of Euros. Lean start‐ups use customer feedback early on to adapt their offering and start the cycle all over again. Thus, at its heart, customer development is about testing a hypothesis and making small adjustments (iterations) or more substantial changes (pivots) to NBD projects.
Closely linked to customer development is agile development, which focuses – in contrast to traditional linear new product development – on building products in short, repeated cycles. Rather than splitting an NBD project into big pieces (e.g. R&D, design, improve, deploy), this method emphasizes dividing the project into smaller activities that enable continuous improvement, in order to develop functionality or performance aspects of a new product fast (e.g. a chemical company producing dispersing additives would focus on one specific functionality of a new additive or a specific part of the formula instead of developing the entire additive before receiving customer feedback for the first time). Companies like Evonik that successfully implemented this lean approach focus on continuously improving the NBD flow and optimizing the whole project into small, iterative steps rather than building production capacity, scaling‐up production and then launching the new offering after years of development (see Box 6.2 for an example).
As you have learned, developing new business opportunities in the chemical industry takes several years and the failure rate is quite high. It is therefore necessary, first, to ensure that the organization learns from its failures and, second, to use appropriate performance measures to evaluate an NBD unit’s progress.
Given the high failure rate of NBD projects, it is important for companies to conduct post‐project reviews to analyse the causes of failure or positive developments that should be applied again. A retrospective analysis of terminated projects enables firms to examine what has been learned from failure and to apply the lessons learned in future projects. However, despite the relevance of learning from failures, studies show that many companies do not review projects at all (e.g. due to time and management constraints) and the small number of projects that are reviewed, are reviewed without established guidelines [37]. In the following, we present the essentials of a project learning or debriefing process that works well, which is based on Evonik’s recommendations for post‐completion audits (PCA) that can be used as a guideline for post‐project reviews in NBD. Table 6.3 summarizes different types of post‐project reviews.
Table 6.3 Overview of post‐completion audits.
Source: own table
Parameter | Project review/audit | Post‐control | Post‐project appraisal | After action review |
Time of execution | After project completion or during each project phase | Exclusively at the end of the project | Approximately 2 years after project completion | During work process |
Carried out by | Review: moderator Audit: external |
Project manager | External post‐project appraisal unit | Facilitator |
Participants | Project team and third parties that were involved | Project manager | Project team and third parties that were involved | Project team |
Purpose | Status classification, early recognition of possible problems | Addition to a more formal project end | Learning from mistakes, knowledge transfer | Learning from mistakes, knowledge transfer |
Benefits | Improvement of team discipline, decreasing vulnerability and validation of strategies | Result is a formal document with project aims, goals, milestones, budget (estimated versus actual) | Best practice generation for large‐scale projects | Immediate reflection of the team’s past actions to improve future actions |
Interaction mode | Face‐to‐face meeting | Non‐cooperative form: conducted by project manager | Document analysis, face‐to‐face meetings | Cooperative team meeting |
Codification | Partly in reports | Partly in reports | Booklets as well as in person | Flip charts |
The PCA should take place from a certain project stage onwards, for example, in Cooper’s Stage‐Gate model after Stage 3 (i.e. “Development”). A PCA should be conducted when an NBD project is terminated, when an NBD project is launched (Stage 5: “Launch”) and approximately two to five years after the launch. The PCA is usually prepared by the project team and presented to the steering committee of the project.
The PCA should contain a business case review and a process review:
Employees in an NBD unit can be doing a great job; however, as the nature of the development process takes several years to reach the first sales, the normal metrics to measure the success of an established business will not work in this case. In order to measure the success of the NBD unit’s efforts, different metrics have been developed by one of the present authors, to give an overview of the performance of a respective NBD unit without considering the details of several highly complex projects the unit is pursuing. This task is fulfilled by defining and measuring a number of key performance indicators (KPIs). As depicted in Figure 6.6, depending on the development phase, different KPIs are used. As the term KPI indicates, these indicators focus on “key performance” metrics and it is, thus, important to keep in mind that they do not create a comprehensive picture. KPIs are “only” indicators and reality might be more complex. For example, the KPI “Number of ideas moved to new phase per FTE and per month” indicates the progress of the innovation pipeline in relation to the number of employees in the unit. Whereas a static view on the innovation pipeline only shows how many projects are at which stage, this KPI shows how many projects are really “alive” and being worked on. Furthermore, the KPI is not only an incentive to push projects forward to higher stages but it also takes terminated projects into consideration. Therefore, it incorporates the reality of a high failure rate, as discussed earlier, and still shows that the unit produces productive outcomes (a terminated project could save the company significant amounts of money, especially when done at an early stage).
The KPI “Weighted number of ideas per FTE” shows the workload of the group and its development over time. Furthermore, it could be benchmarked between similar groups in and outside of a chemical company. Whereas an idea in an early stage needs less time and resources, projects in higher stages require more time and resources and are usually worked on by several employees. Therefore, ideas and projects in different stages need to be weighted in order to have meaningful numbers that can be compared.
3.135.183.89